Literature DB >> 20446076

Bactrian ("double hump") acetaminophen pharmacokinetics: a case series and review of the literature.

Robert G Hendrickson1, Nathanael J McKeown, Patrick L West, Christopher R Burke.   

Abstract

After acute ingestion, acetaminophen (APAP) is generally absorbed within 4 h and the APAP concentration ([APAP]) slowly decreases with a predictable half-life. Alterations in these pharmacokinetic principles have been rarely reported. We report here three cases of an unusual double hump, or Bactrian, pattern of [APAP]. We review the literature to describe the case characteristics of these rare cases. A 38-year-old woman ingested 2 g hydrocodone/65 g acetaminophen. Her [APAP] peaked at 289 mcg/mL (8 h), decreased to 167 mcg/mL (31 h), then increased to 240 mcg/mL (39 h). She developed liver injury (peak AST 1603 IU/L; INR1.6). A 25-year-old man ingested 2 g diphenhydramine/26 g APAP. His [APAP] peaked at 211 mcg/mL (15 h), decreased to 185 mcg/mL (20 h), and increased again to 313 mcg/mL (37 h). He developed liver injury (peak AST 1153; INR 2.1). A 16-year-old boy ingested 5 g diphenhydramine and 100 g APAP. His [APAP] peaked at 470 mcg/mL (25 h), decreased to 313 mcg/mL (36 h), then increased to 354 mcg/mL (42 h). He developed liver injury (peak AST 8,686 IU/L; peak INR 5.9). We report three cases of Bactrian ("double hump") pharmacokinetics after massive APAP overdoses. Cases with double hump pharmacokinetics may be associated with large ingestions (26-100 g APAP) and are often coingested with antimuscarinics or opioids. Several factors may contribute to these altered kinetics including the insolubility of acetaminophen, APAP-induced delays in gastric emptying, opioid or antimuscarinic effects, or enterohepatic circulation. Patients with double hump APAP concentrations may be at risk for liver injury, with AST elevations and peaks occurring later than what is typical for acute APAP overdoses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20446076      PMCID: PMC3550480          DOI: 10.1007/s13181-010-0083-9

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  6 in total

1.  Reported ingested dose of paracetamol as a predictor of risk following paracetamol overdose.

Authors:  Y Leang; D M Taylor; P I Dargan; D M Wood; S L Greene
Journal:  Eur J Clin Pharmacol       Date:  2014-10-01       Impact factor: 2.953

2.  ACMT Position Statement: Duration of Intravenous Acetylcysteine Therapy Following Acetaminophen Overdose.

Authors: 
Journal:  J Med Toxicol       Date:  2016-03-08

3.  Outcomes from massive paracetamol overdose: a retrospective observational study.

Authors:  Daniel J B Marks; Paul I Dargan; John R H Archer; Charlotte L Davies; Alison M Dines; David M Wood; Shaun L Greene
Journal:  Br J Clin Pharmacol       Date:  2017-01-25       Impact factor: 4.335

4.  Hepatic failure despite early acetylcysteine following large acetaminophen-diphenhydramine overdose.

Authors:  George S Wang; Andrew Monte; Dayanand Bagdure; Kennon Heard
Journal:  Pediatrics       Date:  2011-03-14       Impact factor: 7.124

5.  Delayed Acetaminophen Absorption Resulting in Acute Liver Failure.

Authors:  Huiling Tan; Paul Stathakis; Benoj Varghese; Nicholas A Buckley; Angela L Chiew
Journal:  Case Rep Crit Care       Date:  2022-05-07

Review 6.  Evidence for the changing regimens of acetylcysteine.

Authors:  Angela L Chiew; Geoffrey K Isbister; Stephen B Duffull; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2015-11-23       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.